EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Sinomenine Ameliorated Microglial Activation and Neuropathic Pain After Chronic Constriction Injury Via TGF ‐β1/ ALK5 /Smad3 Signalling Pathway

Ling Ling, Min Luo iD, Haolin Yin, Yunyun Tian, Tao Wang, Bangjian Zhang, Li Yin, Yuehui Zhang iD, Jiang Bian iD

Journal of Cellular and Molecular Medicine · 2024

DOI: 10.1111/jcmm.70214 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2024. Verfasst von Ling Ling und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Panzhihua Central Hospital, Panzhihua, Sichuan, China. Hauptthemen laut MEDLINE: Microglia, Morphinans, Smad3 Protein, Neuralgia. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundamental Research Fund for Universities of Yunnan Province, Panzhihua Science and Technology Guiding Project, Transfer Payment Project of Science and Technology Department of Sichuan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sinomenine (SIN), a bioactive isoquinoline alkaloid extracted from the roots and stems of Sinomenium acutum , is efficacious against various chronic pain conditions. Inhibition of microglial activation at the spinal level contributes to the analgesic effects of SIN. Microglial activation in the spinal dorsal horn is key to sensitising neuropathic pain. Consequently, this study aimed to investigate whether the antinociceptive effects of SIN in neuropathic pain are induced through microglial inhibition and the underlying mechanisms. In this study, we observed that SIN alleviated chronic constriction injury (CCI)–induced pain hypersensitivity, spinal microglial activation and neuroinflammation. Consistently, SIN evoked the upregulation of transforming growth factor‐beta1 (TGF‐β1) and phosphorylated Smad3 in the L4–6 ipsilateral spinal dorsal horn of CCI mice. Intrathecal injection of TGF‐β1 siRNA and an activin receptor‐like receptor (ALK5) inhibitor reversed SIN's antinociceptive and antimicroglial effects on CCI mice. Moreover, targeting Smad3 in vitro with siRNA dampened the inhibitory effect of TGF‐β1 on lipopolysaccharide‐induced microglial activation. Finally, targeting Smad3 abrogated SIN‐induced pain relief and microglial inhibition in CCI mice. These findings indicate that the TGF‐β1/ALK5/Smad3 axis plays a key role in the antinociceptive effects of SIN on neuropathic pain, indicating its suppressive ability on microglia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicrogliaMorphinansSmad3 ProteinNeuralgiaTransforming Growth Factor beta1Receptor, Transforming Growth Factor-beta Type ISignal TransductionAnimalsMiceMaleMice, Inbred C57BLDisease Models, AnimalConstriction, PathologicAnalgesicsHyperalgesia

Stichwörter der Autor:innen

Smad3activin receptor–like receptor 5microglianeuropathic painsinomeninetransforming growth factor‐β1

Substanzen

MorphinanssinomenineSmad3 ProteinTransforming Growth Factor beta1Receptor, Transforming Growth Factor-beta Type ITgfbr1 protein, mouseSmad3 protein, mouseAnalgesics

Autor:innen und Institutionen

  • Department of Anesthesiology, Panzhihua Central Hospital, Panzhihua, Sichuan, China.
  • The Third Affiliated Hospital of Zunyi Medical University, The First People's Hospital of Zunyi, Zunyi, Guizhou, China.
  • Department of Anesthesiology, School of Clinic Medicine, Tsinghua University, Beijing, China.
  • Scientific Research and Discipline Construction Office, Panzhihua Central Hospital, Panzhihua, Sichuan, China.
  • Department of Anesthesiology, School of Clinic Medicine, North Sichuan Medical University, Nanchong, Sichuan, China.
  • Department of Neurology, Panzhihua Central Hospital, Panzhihua, Sichuan, China.

ORCID-Profile: Min Luo, Yuehui Zhang, Jiang Bian

Förderung

  • Fundamental Research Fund for Universities of Yunnan Province
  • Panzhihua Science and Technology Guiding Project
  • Transfer Payment Project of Science and Technology Department of Sichuan Province

Zitieren

APA

Ling, L., Luo, M., Yin, H., Tian, Y., Wang, T., Zhang, B., Yin, L., Zhang, Y., & Bian, J. (2024). Sinomenine Ameliorated Microglial Activation and Neuropathic Pain After Chronic Constriction Injury Via TGF ‐β1/ ALK5 /Smad3 Signalling Pathway. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70214

Vancouver

Ling L, Luo M, Yin H, Tian Y, Wang T, Zhang B, et al. Sinomenine Ameliorated Microglial Activation and Neuropathic Pain After Chronic Constriction Injury Via TGF ‐β1/ ALK5 /Smad3 Signalling Pathway. Journal of Cellular and Molecular Medicine. 2024. doi:10.1111/jcmm.70214

BibTeX
@article{Ling2024,
  author = {Ling, Ling and Luo, Min and Yin, Haolin and Tian, Yunyun and Wang, Tao and Zhang, Bangjian and Yin, Li and Zhang, Yuehui and Bian, Jiang},
  title = {Sinomenine Ameliorated Microglial Activation and Neuropathic Pain After Chronic Constriction Injury Via TGF ‐β1/ ALK5 /Smad3 Signalling Pathway},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2024},
  doi = {10.1111/jcmm.70214}
}
Kostenlos starten →